InvestorsHub Logo
Followers 5
Posts 115
Boards Moderated 0
Alias Born 05/06/2006

Re: None

Monday, 07/20/2015 2:47:41 PM

Monday, July 20, 2015 2:47:41 PM

Post# of 346063

0N THE SHELF ?- TNT platform(Cotara,Vivatuxin,Selectine)-2C3-Truncated tissue factor-Oncolymn.


Here is a follow-up to Dumbster's post. I have no idea if patent expirations are in effect,ownership rights have been terminated,or any other legal/science complications are involved with these products. I am bringing all this up to expand the knowlege base of the new investors and to interject some different avenues of thought while we wait for Bavi news.
Much of the potential of the TNT platform has not been fully reseached. If you live in the NYC area you
will see and hear commercials touting the benefits of targeted
radiation therapies (Cyberknife,radioactive seeds,etc.).I find it hard
to believe that the unmatched precision radioactive delivery that
Cotara can provide is a dead end technology . Cotara will "burn up" a
primary tumor as well as its metastases. The TNT antibody can also be
used as an imaging agent.I understand and agree
that bavi without the problems associated with radioactivity-its more
natural immune stimulating approach- and its anti viral potential was
the way to go, but if funds permit sometime in the future the TNT
platform should be explored-it might even be the best type of PS
ellicitor(better than Docetaxel?)and therefore a better complement to Bavi.

The following posts will shed some light as to why many of the old
timers saw something unique about TCLN-PPHM. I'm not a scientist so
anyone feel free to make corrections or update the data.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News